Swiss National Bank
RPRX

Swiss National Bank’s Repros Therapeutics Inc. RPRX Stock Holding History

Swiss National Bank’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-26,400
Closed -$261K – 2648
2014
Q3 		$261K Hold
26,400
– – ﹤0.01% 2376
2014
Q2 		$457K Hold
26,400
– – ﹤0.01% 2211
2014
Q1 		$468K Buy
26,400
+6,200
+31% +$120K ﹤0.01% 2159
2013
Q4 		$370K Hold
20,200
– – ﹤0.01% 2172
2013
Q3 		$541K Sell
20,200
-1,100
-5% -$23.6K ﹤0.01% 1891
2013
Q2 		$393K Buy
+21,300
New +$376K ﹤0.01% 2073

Other funds holding RPRX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
SAM
Senzar Asset Management New York $34.7M AUM 0.56% 1-Year Est. Return
CC
CQS Cayman Camana Bay, Grand Cayman, Cayman Islands $2.26B AUM 1.31% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GAI
General American Investors New York $1.52B AUM 37.94% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Swiss National Bank's RPRX Position: Q4 2014 in Review

Swiss National Bank sold out of Repros Therapeutics Inc. (RPRX) in Q4 2014, closing a stake of 26,400 shares — an estimated $261K sold.

Swiss National Bank first reported a position in RPRX in Q2 2013 and held it in 6 quarters. The position peaked at $541K in Q3 2013. 80 funds tracked by Wall St. Rank hold RPRX as of Q4 2014.

  • Swiss National Bank reported no remaining Repros Therapeutics Inc. position as of Q4 2014 after selling out during the quarter.
  • Swiss National Bank sold 26,400 Repros Therapeutics Inc. shares in Q4 2014, an estimated $261K.
  • Swiss National Bank first reported a position in Repros Therapeutics Inc. in Q2 2013 and held it in 6 quarters.
  • Swiss National Bank's Repros Therapeutics Inc. position peaked at $541K in Q3 2013.
  • 80 funds tracked by Wall St. Rank held Repros Therapeutics Inc. as of Q4 2014.

Based on Swiss National Bank's 13F filing for Q4 2014, filed 3 Feb 2015.